stock offering OpGen Enters $15M Registered Direct Offering Agreement The agreement with a single investor is for an aggregate 150,000 shares of convertible preferred stock and warrants to purchase up to 7.5 million shares of common stock. Cytek Biosciences Prices $200M Initial Public Offering The company, which has developed novel technology for single-cell analyses, is selling an aggregate of 16,749,330 shares of its common stock. Natera Prices, Upsizes Public Stock Offering The company said it plans to use the proceeds for working capital and general corporate purposes, and continued investments in R&D for its core technology. Pacific Biosciences to Acquire Omniome for up to $800M, Expand Invitae Collaboration The sequencing technology firm is also raising approximately $300 million in a PIPE financing and reported preliminary Q2 revenues of $30.5 million. Olink Reports Preliminary Q2 Revenues Between $17.3M and $17.7M, Inks Decode Deal The deal calls for Decode to adopt and serve as an early testing site for Olink's new Explore 3072 proteomics platform, which measures roughly 3,000 proteins. Jun 25, 2021 Angle to Raise £20M Through Stock Placement Jun 14, 2021 Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock May 27, 2021 Singular Genomics Systems Raises $258M in Upsized IPO Mar 29, 2021 SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company Mar 25, 2021 Olink Prices $264M Initial Public Offering Mar 10, 2021 Investor Interest in Proteomics Rising on New, Improving Technologies Premium Feb 11, 2021 Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering Feb 9, 2021 OpGen Enters $25M Direct Offering Agreement Feb 5, 2021 Oncocyte to Raise $35M in Public Stock Offering Feb 5, 2021 Veracyte Prices $550M Public Offering of Common Stock Feb 4, 2021 Quanterix Prices $250M Public Stock Offering Jan 28, 2021 Seer Prices $110.5M Follow-on Stock Offering Jan 27, 2021 Personalis Prices $150M Public Stock Offering Jan 26, 2021 Seer Plans Offering of 3.5M Shares of Common Stock Jan 22, 2021 Predictive Oncology Announces $4.1M Direct Offering Jan 22, 2021 Invitae Prices $400M Common Stock Offering Jan 21, 2021 Genetic Technologies to Raise $6.6M in Direct Offering Jan 21, 2021 CareDx Prices $175M Common Stock Offering Jan 20, 2021 Oncocyte to Raise $25M in Stock Sale to Institutional Investors Jan 20, 2021 Invitae to Raise $400M in Proposed Public Offering Load More Breaking News UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.